A significant medical advancement in combating pancreatic cancer is showing encouraging outcomes after years of research. A new experimental drug, administered daily, is helping prolong patients’ lives by decelerating the progression of this highly lethal cancer.

Dr. Rachna Shroff, the associate director of clinical investigations at the University of Arizona Comprehensive Cancer Center, discussed these findings with Stephanie Sy. The interview highlights the potential impact of this treatment on pancreatic cancer patients.

Stephanie Sy, a correspondent for PBS News Hour, has a solid background in journalism. Her previous roles include working as an anchor and correspondent for networks such as ABC News and Al Jazeera America. She has also contributed to CBSN, CNN International, and PBS News Hour Weekend. Before joining News Hour, she was with Yahoo News, covering the 2018 Midterm Elections and reporting from Donald Trump’s victory party during Election Day 2016.